Cancer support charity Macmillan has revealed its income has increased by 7% and has been able to reach more people
Macmillan’s latest annual findings have shown its income has increased by 7% from last year, up to a record total of £247.7 million.
Legacy giving increased by almost a quarter, with the cancer charity raising nearly £77m from legacies in 2016. Fundraising activities accounted for 99% of Macmillan’s income in 2016, with a small proportion from investments.
Over the past year Macmillan was able to support a record number of people affected by cancer, 55% more than in 2015 at 115,800 people.
In terms of expenditure, the charity spent £245.6m in 2016, with £173.2m on charitable activities and £72.4m on raising funds.
Chief executive Lynda Thomas and chair Julia Palca addressed Macmillan’s supporters in their annual report: “Your generosity gave us the means to invest over £170m into our work to improve the lives of people with cancer, a record amount for Macmillan.”
They added: “By the end of 2016, we were proud to have increased our number of Macmillan nurse posts to 5,200; and in total we had over 6,900 healthcare professional posts, over 660 more than in 2015.”
“In 2016, you raised an astounding £245m, 7% more than the year before. This included our 26th World’s Biggest Coffee Morning bringing in an unbelievable £29.8m.”
As chief executive, Thomas was the highest paid employee with a salary of between £170,000 and £180,000 in 2016.
84 employees earned over £60,000, a rise from 75 the previous year, and the average number of full time staff was 1,642 compared to 1,570 in 2015.
As well as reporting on its key financial changes of the past year, Macmillan raised the issue of the precarious situation faced by health and social care providers.
Palca and Thomas wrote: “While thankfully more people are living longer following a cancer diagnosis, the problem we face is that health and social care providers are already struggling to meet the needs of people with cancer because of financial and capacity pressures.
“It’s due to this worrying situation that the continuing dedication of our supporters, professionals and partners is so important to people with cancer in the UK.”
The full report is available here.
